Now showing items 1-1 of 1
BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis
(Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2015)
In this study, we analyzed the prevalence and clone size of BRAF V600E mutation in 209 patients with multiple myeloma and related the results to clinical phenotype, response and survival. Biopsies were screened for BRAF ...